Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 1,000 shares trading hands.
Resverlogix Stock Performance
The company has a 50 day simple moving average of C$0.06 and a two-hundred day simple moving average of C$0.06. The firm has a market cap of C$13.85 million, a PE ratio of -1.00 and a beta of 0.71.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- Business Services Stocks Investing
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Most Volatile Stocks, What Investors Need to Know
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
